Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern.
Experimental and Clinical Psychopharmacology · 2025
DOI: 10.1037/pha0000761 ↗At a glance
Journal article in Experimental and Clinical Psychopharmacology, 2025. Written by Ty S Schepis and 6 co-authors. Institution: Department of Health Behavior and Biological Sciences, Center for the Study of Drugs, Alcohol, Smoking and Health (DASH Center), School of Nursing, U…. Major MEDLINE topics: Central Nervous System Stimulants, Methamphetamine, Substance-Related Disorders, Cocaine-Related Disorders. Cited 3 times so far (Crossref). The full text is freely available in PubMed Central. Funded by: U.S. Food and Drug Administration, NIDA NIH HHS, National Institutes of Health; National Institute on Drug Abuse.
Abstract (original language)
Psychostimulant misuse and use disorders are major drivers of morbidity and fatal overdose in the United States, but little is known about how differences in psychostimulant use patterns relate to Diagnostic and Statistical Manual, Diagnostic and Statistical Manual of Mental Disorders, 4th edition and Diagnostic and Statistical Manual of Mental Disorders, 5th edition (DSM-5) stimulant substance use disorder (SUD) profiles. We used nationally representative U.S. data to assess the links between polystimulant use patterns and stimulant SUD prevalence, symptom counts, and DSM-5 stimulant SUD severity. Data were from the 2015-2019 and 2020 National Survey on Drug Use and Health. Participants (n = 282,786) were grouped by past-year psychostimulant use patterns: (a) nonmedical use of prescription stimulants (NUPS) only; (b) cocaine-only; (c) methamphetamine-only; and (d) polystimulant use. Analyses comparing groups used logistic regressions for prevalence of past-year Diagnostic and Statistical Manual of Mental Disorders, 4th edition (2015-2019 and 2020) and DSM-5 (2020 only) stimulant SUD, negative binomial regressions for stimulant SUD symptom counts, and multinomial regressions for DSM-5 stimulant SUD severity. Those with past-year methamphetamine-only or polystimulant use had significantly higher Diagnostic and Statistical Manual of Mental Disorders, 4th edition and DSM-5 prevalence rates, symptom counts, and DSM-5 severities of stimulant SUD than those with NUPS or cocaine use only. Depending on Diagnostic and Statistical Manual of Mental Disorders version, 34%-47% of those engaged in polystimulant use and 48%-54% of those with methamphetamine use only met criteria for a stimulant SUD, versus 9%-17% for NUPS-only and 16%-24% for cocaine-only. For 2020, roughly two thirds of those with methamphetamine-only use had stimulant SUD symptoms. Individuals with methamphetamine and/or polystimulant use may have different service needs than those with NUPS or cocaine use only. (PsycInfo Database Record (c) 2025 APA, all rights reserved).
Subjects
MeSH terms (MEDLINE)
Substances
Authors and institutions
- Department of Health Behavior and Biological Sciences, Center for the Study of Drugs, Alcohol, Smoking and Health (DASH Center), School of Nursing, University of Michigan.
ORCID profiles: Ty S Schepis
Funding
- U.S. Food and Drug Administration
- NIDA NIH HHS
- National Institutes of Health; National Institute on Drug Abuse
- National Institutes of Health
Cite
APA
Schepis, T. S., Veliz, P. T., McCabe, V. V., Werner, K. S., Pasman, E., Wilens, T. E., & McCabe, S. E. (2025). Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern. Experimental and Clinical Psychopharmacology. https://doi.org/10.1037/pha0000761
Vancouver
Schepis TS, Veliz PT, McCabe VV, Werner KS, Pasman E, Wilens TE, et al. Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern. Experimental and Clinical Psychopharmacology. 2025. doi:10.1037/pha0000761
BibTeX
@article{Schepis2025,
author = {Schepis, Ty S and Veliz, Philip T and McCabe, Vita V and Werner, Kennedy S and Pasman, Emily and Wilens, Timothy E and McCabe, Sean Esteban},
title = {Severity of stimulant use disorder by psychostimulant type and polystimulant use pattern},
journal = {Experimental and Clinical Psychopharmacology},
year = {2025},
doi = {10.1037/pha0000761}
}
EUVIMED